|
2024
|
P/S
|
Pharmaceutical and medicinal preparations. |
|
|
P/S
|
Medicinal and pharmaceutical preparations. |
|
|
Invention
|
Vaccine. The present invention relates to conjugates comprising polysaccharides comprising 3- deo... |
|
|
Invention
|
A process for preparing stable paliperidone ester formulation. The present disclosure relates to ... |
|
|
Invention
|
Stabilizer composition for immunogenic compositions, stabilized immunogenic compositions, methods... |
|
|
Invention
|
Expression cassettes for protein expression, method(s) and application(s) thereof. The present di... |
|
|
Invention
|
Streptococcus pneumoniae. Streptococcus pneumoniae serotypes 2, 15A, 15C & 35B and process for th... |
|
2023
|
Invention
|
Method for the purification of capsular polysaccharides. The present invention broadly relates to... |
|
|
Invention
|
Expression of pneumococcal surface protein a (pspa).
The present invention relates to expression... |
|
2022
|
Invention
|
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates.
The ... |
|
|
P/S
|
Vaccine preparations; human vaccine preparations; oral
vaccine preparations. |
|
|
P/S
|
Vaccine preparations; human vaccine preparations; oral vaccine preparations |
|
|
Invention
|
Constructs and methods for increased expression of polypeptides.
The present invention relates t... |
|
|
Invention
|
Constructs and methods for increased expression of polypeptides. The present invention relates to... |
|
|
Invention
|
Activated-quenched polysaccharide and improved methods for quantification of polysaccharide in a ... |
|
2021
|
Invention
|
Risperidone microspheres, process for their prepartion and uses thereof. The present invention re... |
|
2020
|
Invention
|
Methods for quantification of carbohydrates. The present invention provides a colorimetric based ... |
|
|
Invention
|
Method for separation of protein and other impurities from microbial capsular polysaccharides. Th... |
|
|
Invention
|
N-terminal extension sequence for expression of recombinant therapeutic peptides.
The invention ... |
|
|
Invention
|
N-terminal extension sequence for expression of recombinant therapeutic peptides. The invention r... |
|
|
Invention
|
Multivalent vaccine composition. The present invention pertains to a multivalent vaccine formulat... |
|
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions. Streptococcus pne... |
|
|
Invention
|
Multivalent pneumococcal conjugate vaccine compositions. Streptococcus pneumoniaeStreptococcus pn... |
|
2019
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate vaccine.
The present invention relates... |
|
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate vaccine. Streptococcus pneumoniae Strep... |
|
|
Invention
|
Inactivated poliomyelitis vaccine composition. The present invention provides inactivated poliomy... |
|
|
Invention
|
Purified capsular polysaccharides of streptococcus pneumoniae. Streptococcus pneumoniaeStreptococ... |
|
|
Invention
|
Vaccine formulations comprising preservative. The present invention relates to vaccine formulatio... |
|
|
Invention
|
Vaccine formulations comprising preservative system. The present invention relates to vaccine for... |
|
|
Invention
|
Semi-synthetic meningococcal conjugate vaccine. The present invention relates to novel semi-synth... |
|
|
Invention
|
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates. The p... |
|
|
Invention
|
Expression of pneumococcal surface protein a (pspa). The present invention relates to expression ... |
|
|
Invention
|
Process for the preparation of dalteparin sodium. The present invention provides an improved proc... |
|
|
Invention
|
Improved process for the preparation of dalteparin sodium. The present invention provides an impr... |
|
2018
|
Invention
|
Process for the preparation of low molecular weight heparin. The present invention provides an im... |
|
|
Invention
|
197. 197 gene, wherein the method comprises growing the strain in media free of animal-derived co... |
|
|
Invention
|
An improved method for high level production of crm. The present invention provides an improved m... |
|
2016
|
Invention
|
Industrially scalable process for recovering biologically active recombinant carrier proteins. Es... |
|
|
Invention
|
Industrially scalableprocess for recovering biologically active recombinant carrier proteins. The... |
|
|
Invention
|
Multivalent pneumococcal conjugate vaccine. 197, pneumococcal surface protein A (PspA), pneumococ... |
|
|
Invention
|
Multivalent pneumococcal conjugate vaccine. The present invention relates to a multivalent Pneumo... |
|
|
Invention
|
Method for preparation of aluminium phosphate gel for application in vaccine formulations. The pr... |
|
2015
|
Invention
|
Soft gelatin capsule composition of anti-tussive agents. The present invention relates to a soft-... |
|
|
Invention
|
Codon optimized polynucleotide for high level expression of crm197. Escherichia coli and a method... |
|
|
Invention
|
Novel semi-synthetic meningococcal conjugate vaccine.
The present invention relates to novel sem... |
